Neogen (NEOG) Short term Debt (2024 - 2025)
Neogen (NEOG) posted quarterly Short term Debt of $19.3 million for Q2 2025, up 688.72% year-over-year from $2.4 million in Q2 2024, and up 688.72% quarter-over-quarter from $2.4 million in Q2 2024.
Neogen (NEOG) Short term Debt (2024 - 2025) Analysis & Trends
Neogen's Short term Debt history runs 2 years deep, the most recent figure standing at $19.3 million for Q2 2025.
- In Q2 2025, Short term Debt rose 688.72% year-over-year to $19.3 million; the TTM figure through May 2025 stood at $19.3 million (up 688.72% YoY), while the FY2025 annual figure was $19.3 million, up 688.72% from the prior year.
- Short term Debt for Q2 2025 stood at $19.3 million, up from $2.4 million in the prior quarter.
- The five-year high for Short term Debt was $19.3 million in Q2 2025, with the low at $2.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Neogen | 2.56 Bn | 2.37 Bn | 107.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 19.30 Mn |
| May 31, 2024 | 2.45 Mn |